Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

155.17 -0.33 (-0.21%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Is Johnson & Johnson a Buy Now?
Second-quarter results suggest the spinoff of the company's slow-growing consumer goods segment is having the intended effect. 
Via The Motley Fool
2 Magnificent S&P 500 Dividend Stocks Down 19% and 41% to Buy and Hold Forever
The market can be unpredictable in the short run, but over the long term, the best companies will build lasting wealth for their shareholders. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Why Johnson & Johnson Stock Was a Winner on Wednesday
The company did a fine job of boosting sales of numerous drugs. 
Via The Motley Fool
Stock Of The Day: Johnson & Johnson Hits Crucial Roadblock — Can It Break Through?
The chart of Johnson & Johnson shows a clear illustration of an important market dynamic. Certain price levels that are more important than others. 
Via Benzinga
Johnson & Johnson (JNJ) Q2 2024 Earnings Call Transcript
JNJ earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Nasdaq 100 Suffers Worst Day In 11 Months As Chipmakers Tumble On China Curbs; Magnificent 7 Wipe Out $500B : What's Driving Markets Wednesday?
It’s deep red on Wall Street on Wednesday, with tech stocks sharply falling amid a semiconductor broad-based selloff following news that the Biden administration is hastening export restrictions to... 
Via Benzinga
European Commission Faces Court Criticism Over COVID Vaccine Contract Transparency Ahead Of Vote on Ursula Von Der Leyen's Reappointment
European Commission faces scrutiny over COVID vaccine contract transparency ahead of key vote. Legal challenges and implications discussed. 
Via Benzinga
Exposures COVID-19
Johnson And Johnson Continues To Focus On Medical Innovation
On Wednesday, Johnson & Johnson (NYSE: JNJ) reported its second quarter results that reflected a strong momentum of its medtech and innovative medicine divisions. 
Via Benzinga
This Medical Giant's Stock Rebounds: A 15% Upside Is the Minimum
Johnson & Johnson reported a solid quarter for Q2 but issued mixed guidance. The critical detail is that sequential growth continues, and YOY growth is on tap. 
Via MarketBeat
Exposures COVID-19
JNJ Q2 2024 Sales Surge To $22.4 Billion, Beating Expectations
Johnson & Johnson reported a 4.3% increase in sales to $22.4 billion in Q2 2024, with operational growth at 6.6% and adjusted EPS rising by 10.2% to $2.82. 
Via Talk Markets
Smart Money Is Betting Big In JNJ Options
Via Benzinga
NYSE:JNJ: good value for what you're paying.
JOHNSON & JOHNSON (NYSE:JNJ) stands out as a stock that provides good value for the fundamentals it showcases. 
Via Chartmill
Nasdaq Dips 300 Points; Johnson & Johnson Earnings Top Estimates
Via Benzinga
Johnson & Johnson's Q2 Earnings: Revenue And Profit Beat On Strong Pharma Sales, Annual Profit Outlook Lowered On M&A Costs
Johnson & Johnson's Q2 earnings report shows a 10.2% rise in adjusted EPS to $2.82 and a 4.3% increase in sales to $22.45 billion, surpassing expectations. The company highlights strong performance in... 
Via Benzinga
Nasdaq, S&P 500 Futures Plunge After Trump's Comments And ASML's Weak Forecast Deepens Tech Sell-Off: AI Narrative May Be Priced In, Says Analyst
Sentiment will likely reverse course, with the index futures trading notably lower early Wednesday. The recent run-up ideally should render the mood cautious, and the caution may intensify as the first... 
Via Benzinga
Topics Artificial Intelligence Government Stocks
Exposures Artificial Intelligence Political US Equities
3 Dividend Stocks With 3%+ Yields to Upgrade Your Annual Income
These high-yield dividend stocks will ensure steady quarterly income and help your money grow at little risk. 
Via InvestorPlace
Johnson & Johnson Earnings Top, But Dow Stock Falls On Lowered Guidance
The Dow giant reported before the open. Shares are in a long downtrend. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2024
From Johnson & Johnson
Via Business Wire
Johnson & Johnson reports Q2 2024 results
From Johnson & Johnson
Via Business Wire
ASML, United Airlines And 3 Other Stocks To Watch Heading Into Wednesday
With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Dow Jones Closes At Record High As Traders Turn Bullish Amid Hopes Of Fed Cutting Rates In September
The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, with the index remaining in the "Greed" zone on Tuesday. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock?
Johnson & Johnson has beaten earnings per share in more than 10 straight quarters. Will the trend continue in Q2? 
Via Benzinga
3 Safe Dividend Kings to Recession-Proof Your Portfolio
These safe dividend kings belong to an elite club of companies that have paid dividends for more than 50 years. 
Via InvestorPlace
Johnson & Johnson: Bullish Charts Signal Strong Setup Before Q2 Earnings
Johnson & Johnson reports Q2 earnings, expected EPS of $2.7 and revenues of $22.3B. Stock is bullish, above key moving averages. 
Via Benzinga
How To Earn $500 A Month From Johnson & Johnson Stock Ahead Of Q2 Earnings
JNJ to release 2Q financial results on July 17. Expected earnings $2.70/share, revenue $22.29B. Investors eye 3.32% dividend yield for gains. 
Via Benzinga
If You Can Only Buy One Dow Stock in July, It Better Be One of These 3 Names
These dow stocks to buy are well-positioned to provide significant returns to investors due to their high growth potential. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Dow Closes At New High As Q2 Earnings Season Heats Up
It’s a great start to the trading week. After months of trailing its major-index brethren, the Dow Jones reaches today’s closing bell at a new record high: 40,211. Q2 earnings are coming in well so... 
Via Talk Markets
Topics Stocks
Exposures US Equities
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
NKGen Biotech Appoints Dr. Marco Gottardis to its Board of Directors
From NKGen Biotech
Via GlobeNewswire
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
These companies stand out for their pedigrees, robust financials, and future growth prospects. 
Via The Motley Fool
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.